Skip to main content

Articles

Page 2 of 75

  1. Bone tissue engineering (BTE) emerged as one of the exceptional means for bone defects owing to it providing mechanical supports to guide bone tissue regeneration. Great advances have been made to facilitate t...

    Authors: Hongqi Zhao, Chaoxu Liu, Yang Liu, Qing Ding, Tianqi Wang, Hao Li, Hua Wu and Tian Ma
    Citation: Stem Cell Research & Therapy 2023 14:7
  2. Cell therapy is a key technology to prevent sacrificing normal skin. Although some studies have shown the promise of human epidermal stem cells (EpiSCs), the efficacy, biosafety and quality control of EpiSC th...

    Authors: Xiaohong Zhao, Xue Li, Ying Wang, Yicheng Guo, Yong Huang, Dalun Lv, Mingxing Lei, Shicang Yu, Gaoxing Luo and Rixing Zhan
    Citation: Stem Cell Research & Therapy 2023 14:4
  3. Alzheimer’s disease (AD) is a common progressive neurodegenerative disease characterized by memory impairments, and there is no effective therapy. Neural stem/progenitor cell (NSPC) has emerged as potential no...

    Authors: Zijing Zhou, Ben Shi, Yaxing Xu, Jinyu Zhang, Xin liu, Xinghong Zhou, Baofeng Feng, Jun Ma and Huixian Cui
    Citation: Stem Cell Research & Therapy 2023 14:3
  4. Traumatic brain injury (TBI) is a disease with high mortality and morbidity, which leads to severe neurological dysfunction. Neurogenesis has provided therapeutic options for treating TBI. Brain derived neurot...

    Authors: Na Wu, Xiaochuan Sun, Chao Zhou, Jin Yan and Chongjie Cheng
    Citation: Stem Cell Research & Therapy 2023 14:2
  5. Transplantation of differentiated cells from human-induced pluripotent stem cells (hiPSCs) holds great promise for clinical treatments. Eliminating the risk factor of malignant cell transformation is essential...

    Authors: Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Kiyohiro Hashimoto, Nozomu Sakai, Shinya Asano, Saori Watanabe-Matsumoto, Takeshi Watanabe, Bunnai Saito, Hirokazu Matsumoto, Hikaru Ueno, Ryo Ito and Taro Toyoda
    Citation: Stem Cell Research & Therapy 2023 14:1
  6. BMP9-stimulated DPSCs, SCAPs and PDLSCs are effective candidates for repairing maxillofacial bone defects in tissue engineering, while the most suitable seed cell source among these three hDMSCs and the optima...

    Authors: Yuxin Zhang, Wenping Luo, Liwen Zheng, Jing Hu, Li Nie, Huan Zeng, Xi Tan, Yucan Jiang, Yeming Li, Tianyu Zhao, Zhuohui Yang, Tong-Chuan He and Hongmei Zhang
    Citation: Stem Cell Research & Therapy 2022 13:535
  7. Rett syndrome (RTT), mainly caused by mutations in methyl-CpG binding protein 2 (MECP2), is one of the most prevalent neurodevelopmental disorders in girls. However, the underlying mechanism of MECP2 remains l...

    Authors: Ya-Jie Xu, Pei-Pei Liu, Zhong-Ze Yan, Ting-Wei Mi, Ying-Ying Wang, Qian Li, Zhao-Qian Teng and Chang-Mei Liu
    Citation: Stem Cell Research & Therapy 2022 13:534
  8. Bone marrow mesenchymal stromal cells (BMSCs) are promising for therapeutic use in cartilage repair, because of their capacity to differentiate into chondrocytes. Often, in vitro differentiation protocols empl...

    Authors: Daniele Zuncheddu, Elena Della Bella, Dalila Petta, Cecilia Bärtschi, Sonja Häckel, Moritz C. Deml, Martin J. Stoddart, Sibylle Grad and Valentina Basoli
    Citation: Stem Cell Research & Therapy 2022 13:533
  9. Sprouting angiogenesis is an important mechanism for morphogenetic phenomena, including organ development, wound healing, and tissue regeneration. In regenerative medicine, therapeutic angiogenesis is a clinic...

    Authors: Takanori Sano, Tadaaki Nakajima, Koharu Alicia Senda, Shizuka Nakano, Mizuho Yamato, Yukinori Ikeda, Hedele Zeng, Jun-ichi Kawabe and Yukiko T. Matsunaga
    Citation: Stem Cell Research & Therapy 2022 13:532
  10. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iPSC-CMs) do not display all hallmarks of mature primary cardiomyocytes, especially the ability to use fatty acids (FA) as an energy source, c...

    Authors: Nino Chirico, Elise L. Kessler, Renée G. C. Maas, Juntao Fang, Jiabin Qin, Inge Dokter, Mark Daniels, Tomo Šarić, Klaus Neef, Jan-Willem Buikema, Zhiyong Lei, Pieter A. Doevendans, Joost P. G. Sluijter and Alain van Mil
    Citation: Stem Cell Research & Therapy 2022 13:531
  11. Authors: Rongchuan Yue, Wenbin Fu, Xiang Liao, Cong Lan, Qiao Liao, Liangpeng Li, Dezhong Yang, Xuewei Xia, Xiongwen Chen, Chunyu Zeng and Wei Eric Wang
    Citation: Stem Cell Research & Therapy 2022 13:530

    The original article was published in Stem Cell Research & Therapy 2017 8:17

  12. Tissue organoids generated from human pluripotent stem cells are valuable tools for disease modelling and to understand developmental processes. While recent progress in human cardiac organoids revealed the ab...

    Authors: Beatrice Xuan Ho, Jeremy Kah Sheng Pang, Ying Chen, Yuin-Han Loh, Omer An, Henry He Yang, Veerabrahma Pratap Seshachalam, Judice L. Y. Koh, Woon-Khiong Chan, Shi Yan Ng and Boon Seng Soh
    Citation: Stem Cell Research & Therapy 2022 13:529
  13. Nowadays, diabetes mellitus is known as a silent killer because individual is not aware that he has the disease till the development of its complications. Many researchers have studied the use of stem cells in...

    Authors: Alyaa Farid, Hebatallah Haridyy, Salma Ashraf, Selim Ahmed and Gehan Safwat
    Citation: Stem Cell Research & Therapy 2022 13:528
  14. Brain tumors are one of the most mortal cancers, leading to many deaths among kids and adults. Surgery, chemotherapy, and radiotherapy are available options for brain tumor treatment. However, these methods ar...

    Authors: Elham Ghasempour, Shilan Hesami, Elaheh Movahed, Saeed Heidari keshel and Mohammad Doroudian
    Citation: Stem Cell Research & Therapy 2022 13:527
  15. The effects of traumatic brain injury (TBI) can include physical disability and even death. The development of effective therapies to promote neurological recovery is still a challenging problem. 3D-printed bi...

    Authors: Xiao-Yin Liu, Zhe-Han Chang, Chong Chen, Jun Liang, Jian-Xin Shi, Xiu Fan, Qi Shao, Wei-Wei Meng, Jing-Jing Wang and Xiao-Hong Li
    Citation: Stem Cell Research & Therapy 2022 13:525
  16. Heterotopic ossification (HO) is the formation of bone in non-osseous tissues, such as skeletal muscles. The HO could have a genetic or a non-genetic (acquired) background, that is, it could be caused by muscu...

    Authors: Łukasz Pulik, Bartosz Mierzejewski, Aleksandra Sibilska, Iwona Grabowska, Maria Anna Ciemerych, Paweł Łęgosz and Edyta Brzóska
    Citation: Stem Cell Research & Therapy 2022 13:523
  17. MicroRNAs (miRNAs) are non-coding single-stranded RNA molecules encoded by endogenous genes, which play a vital role in cell generation, metabolism, apoptosis and stem cell differentiation. C3H10T1/2, a mesenc...

    Authors: Wei Huang, Xiaoyue Wu, Shuaixi Xiang, Mingxin Qiao, Hanfei Li, Yujie Zhu, Zhou Zhu and Zhihe Zhao
    Citation: Stem Cell Research & Therapy 2022 13:521
  18. Mesenchymal stem cells (MSCs) driven gene directed enzyme prodrug therapy is a promising approach to deliver therapeutic agents to target heterogenous solid tumours. To democratize such a therapy, cryopreserva...

    Authors: Yoon Khei Ho, Kin Man Loke, Jun Yung Woo, Yee Lin Lee and Heng-Phon Too
    Citation: Stem Cell Research & Therapy 2022 13:519
  19. Bone-related diseases are major contributors to morbidity and mortality in elderly people and the current treatments result in insufficient healing and several complications. One of the promising areas of rese...

    Authors: Armin Ahmadi, Radman Mazloomnejad, Mohammadreza Kasravi, Babak Gholamine, Soheyl Bahrami, Mohammad Mahdi Sarzaeem and Hassan Niknejad
    Citation: Stem Cell Research & Therapy 2022 13:518
  20. Human umbilical cord mesenchymal stem cells (hUC-MSCs) are increasingly being studied in clinical trials of end-stage liver disease because of their good tissue repair and anti-inflammatory effects. hUC-MSC ex...

    Authors: Ying Shi, Xiaoguang Yang, Shuyue Wang, Yulun Wu, Lihua Zheng, Yufang Tang, Yanhang Gao and Junqi Niu
    Citation: Stem Cell Research & Therapy 2022 13:517
  21. Endothelial progenitor cells (EPCs) contribute to the recovery of neurological function after ischemic stroke. Indirect revascularization has exhibited promising effects in the treatment of cerebral ischemia r...

    Authors: Kuo-Chuan Wang, Ling-Yu Yang, Jing-Er Lee, Vicent Wu, Te-Fu Chen, Sung-Tsang Hsieh and Meng-Fai Kuo
    Citation: Stem Cell Research & Therapy 2022 13:516
  22. Tendon regeneration is difficult because detailed knowledge about tendon progenitor cells (TPCs), which produce tenocytes to repair tendon tissue, has not been revealed. Mohawk homeobox (MKX) is a marker of TP...

    Authors: Yuki Fujisawa, Lu Ming, Daisuke Yamada, Tomoka Takao and Takeshi Takarada
    Citation: Stem Cell Research & Therapy 2022 13:515
  23. The mesenchymal stem cells (MSCs) were used to repair tissue injury. However, the treatment effect was not satisfactory. We investigated whether lncRNA MIR155HG could promote survival and migration of MSCs und...

    Authors: Xiao Bai, Zaiwen Qi, Mingzhen Zhu, Zhuangzhuang Lu, Xin Zhao, Lining Zhang and Guangmin Song
    Citation: Stem Cell Research & Therapy 2022 13:512
  24. Bone injury plagues millions of patients worldwide every year, and it demands a heavy portion of expense from the public medical insurance system. At present, orthopedists think that autologous bone transplant...

    Authors: Yu-Hao Wang, Cheng-Zhi Zhao, Ren-Yi Wang, Qian-Xin Du, Ji-Yuan Liu and Jian Pan
    Citation: Stem Cell Research & Therapy 2022 13:511

    The Correction to this article has been published in Stem Cell Research & Therapy 2022 13:524

  25. Mesenchymal stem cells (MSCs) have shown immense therapeutic potential for various brain diseases. Intrathecal administration of MSCs may enhance their recruitment to lesions in the central nervous system, but...

    Authors: Ye Ran, Yankai Dong, Yuejiao Li, Jundong Xie, Shubin Zeng, Chuanlei Liang, Wei Dai, Wenjing Tang, Yaojiong Wu and Shengyuan Yu
    Citation: Stem Cell Research & Therapy 2022 13:507
  26. Authors: Qin He, Lingshu Wang, Ruxing Zhao, Fei Yan, Sha Sha, Chen Cui, Jia Song, Huiqing Hu, Xinghong Guo, Mengmeng Yang, Yixin Cui, Yujing Sun, Zheng Sun, Fuqiang Liu, Ming Dong, Xinguo Hou…
    Citation: Stem Cell Research & Therapy 2022 13:505
  27. Cell-based therapy using adipose-derived mesenchymal stem cells (ADSCs) is a promising treatment strategy for neurogenic bladder (NB) associated with spinal cord injury (SCI). However, therapeutic efficacy is ...

    Authors: Jiasheng Chen, Lin Wang, Meng Liu, Guo Gao, Weixin Zhao, Qiang Fu and Ying Wang
    Citation: Stem Cell Research & Therapy 2022 13:503
  28. Allogeneic therapeutic cells may be rejected if they express HLA alleles not found in the recipient. As finding cell donors with a full HLA match to a recipient requires vast donor pools, the use of HLA homozy...

    Authors: Jonna Clancy, Kati Hyvärinen, Jarmo Ritari, Tiina Wahlfors, Jukka Partanen and Satu Koskela
    Citation: Stem Cell Research & Therapy 2022 13:502
  29. Human dermal fibroblasts (HDFs) have the potential to differentiate into vascular endothelial cells (VECs), but their differentiation rate is low and the mechanism involved is not clear. The small molecule pat...

    Authors: XiaoLing Cui, XiaoTan Wang, Jie Wen, Xiao Li, Nan Li, XuXiao Hao, BaoXiang Zhao, Xunwei Wu and JunYing Miao
    Citation: Stem Cell Research & Therapy 2022 13:501
  30. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important curative therapy for adult acute lymphoblastic leukemia (ALL). For patients who lack a human leukocyte antigen (HLA)-matched sibli...

    Authors: Guangyu Sun, Baolin Tang, Kaidi Song, Yue Wu, Meijuan Tu, Xiang Wan, Wen Yao, Liangquan Geng, Ping Qiang and Xiaoyu Zhu
    Citation: Stem Cell Research & Therapy 2022 13:500
  31. Localized scleroderma causes cosmetic disfigurement, joint contractures, and other functional impairment, but no currently available medications can reverse the resulting skin lesions. Fat grafting is benefici...

    Authors: Jing Wang, Junrong Cai, Qian Zhang, Jiaqing Wen, Yunjun Liao and Feng Lu
    Citation: Stem Cell Research & Therapy 2022 13:499
  32. In enteric neural stem cell (ENSC) therapy for enteric neuropathy, the gut is ostensibly accessible via laparotomy, laparoscopy or endoscopy, whereas its elongated configuration and multilayered structures sub...

    Authors: Jeng-Chang Chen
    Citation: Stem Cell Research & Therapy 2022 13:498
  33. Microvesicles (MVs) derived from human bone marrow mesenchymal stem cell (MSC) were demonstrated to restore lung protein permeability and attenuate acute lung injury. In our previous study, we found that MSC M...

    Authors: Lifang Ye, Jieqiong Song, Yijun Zheng, Ming Zhong, Jun Liu, Duming Zhu and Shuling Hu
    Citation: Stem Cell Research & Therapy 2022 13:496
  34. Hepatic fibrosis is a common pathologic stage in chronic liver disease development, which might ultimately lead to liver cirrhosis. Accumulating evidence suggests that adipose-derived stromal cells (ADSCs)-bas...

    Authors: Baitong Wu, Jiuxing Feng, Jingyi Guo, Jian Wang, Guanghui Xiu, Jiaqi Xu, Ke Ning, Bin Ling, Qingchun Fu and Jun Xu
    Citation: Stem Cell Research & Therapy 2022 13:494
  35. Pulmonary fibrosis (PF) is a chronic and relentlessly progressive interstitial lung disease in which the accumulation of fibroblasts and extracellular matrix (ECM) induces the destruction of normal alveolar st...

    Authors: Wenzhao Cheng, Yiming Zeng and Dachun Wang
    Citation: Stem Cell Research & Therapy 2022 13:492
  36. Mesenchymal stem/stromal cells (MSCs) acquire immunosuppressive capacity only in an inflammatory microenvironment. This can be recapitulated in vitro by treating MSCs with inflammatory cytokines TNFα and IFNγ, wh...

    Authors: Chenchang Xu, Chao Feng, Peiqing Huang, Yinghong Li, Rui Liu, Chunxiao Liu, Yuyi Han, Lei Chen, Yayun Ding, Changshun Shao and Yufang Shi
    Citation: Stem Cell Research & Therapy 2022 13:491
  37. Human amniotic mesenchymal stem cells (hAMSCs) are splendid cell sources for clinical application in the administration of numerous refractory and relapse diseases. Despite the preferable prospect of serum-fre...

    Authors: Yunyan Sun, Ti-er Wang, Qianwen Hu, Wenxia Zhang, Yun Zeng, Xun Lai, Leisheng Zhang and Mingxia Shi
    Citation: Stem Cell Research & Therapy 2022 13:490

2021 Journal Metrics